Sign In

Ryan Fiorini

Co-Founder and Chief Executive Officer at Blinktbi, Inc

Ryan Fiorini is a seasoned professional known for his remarkable contributions in the biotechnology industry, well-versed in biotech start-ups, license negotiations, patent law, and life science expertise.

Ryan Fiorini's career highlights include serving as the Founder and Chief Operating Officer of Immunologix, which was later acquired by Intrexon Corporation. Subsequently, he took on pivotal roles such as Vice President of Antibody Development and Vice President of Therapeutic Business Development at Intrexon Corporation.

After leaving Intrexon, Ryan Fiorini held the positions of President and CEO at Perle Bioscience, where he spearheaded the development of novel therapeutics for Type 1 diabetes. He then transitioned to consultancy roles for various entities while also co-founding Blinktbi, Inc. in May 2017.

At Blinktbi, Ryan Fiorini embarked on introducing innovative medical technology with the FDA-cleared EyeStat device, focusing on diagnosing traumatic brain injuries, early detection of neurological diseases, and sobriety measurement through the blink reflex.

Educationally, Ryan Fiorini holds degrees ranging from a Ph.D. in Microbiology and Immunology, an MHA in Health Administration, an MBA in Business Administration, to a BS in Biology and Chemistry from reputable institutions like Medical University of South Carolina and The Citadel.

Ryan Fiorini's extensive career has also seen him in roles as an Adjunct Professor, Licensing and Commercialization Manager, and involvement in various influential organizations within the biotech sector.

Ryan Fiorini
Add to my network

Location

Charleston, South Carolina, United States